The value of thinly spread QALYs

PharmacoEconomics

Volumn 24, Issue 9, 2006, Pages 845-853

  Mortimer, Duncan ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISPERSION; FUNDING; HEALTH CARE DELIVERY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SOCIAL WELFARE;

ECONOMICS, PHARMACEUTICAL; HEALTH CARE RATIONING; HEALTH POLICY; HUMANS; QUALITY-ADJUSTED LIFE YEARS; SOCIAL WELFARE;

EID: 33748361821     PISSN: 11707690     EISSN: 11707690     Source Type: Journal    
DOI: 10.2165/00019053-200624090-00003     Document Type: Review

References (40)

1. Dolan P, Shaw R, Tsuchiya A, et al. QALY maximisation and people's preferences: a methodological review of the literature. Health Econ 2005; 14: 197-208
2. Olsen JA. A note on eliciting distributive preferences for health. J Health Econ 2000; 19: 541-50
3. Choudhry N, Slaughter P, Sykora K, et al. Distributional dilemmas in health policy: large benefits for a few or smaller benefits for many? J Health Serv Res Policy 1997; 2 (4): 212-6
4. Pinto-Prades JL, Lopez-Nicol A. More evidence on the plateau effect. Med Decis Making 1998; 18: 287-16
5. Rodriguez-Miguez E, Pinto-Prades JL. Measuring the social importance of concentration or dispersion of individual health benefits. Health Econ 2002; 11: 43-53
6. Olsen JA, Heiberg I. Applying the person trade-off method to derive equity weights: the case of remaining life years. The World Congress of the International Health Economics Association (iHEA); 1996 May 19-23; Vancouver
7. Johannesson M, Johansson PO. Is the valuation of a QALY gained independent of age? Some empirical evidence. J Health Econ 1997; 16 (5): 589-99
8. Maynard A. Rationing health care: what use citizens' juries and priority committees if principles of rationing remain implicit and confused? BMJ 1996; 313 (7071): 1499-501
9. Wagstaff A. QALYs and the equity-efficiency trade-off. J Health Econ 1991; 10: 21-41
10. Culyer AJ, Wagstaff A. Equity and equality in health and health care. J Health Econ 1993; 12: 431-57
11. Nord E, Richardson J, Street A, et al. Maximising health benefits vs egalitarianism: an Australian survey of health issues. Soc Sci Med 1995; 41 (10): 1429-37
12. Institute of Medicine. New vaccine development: establishing priorities. Vol. II: diseases of importance in developing countries. Washington, DC: National Academy Press, 1986
13. Lewis PA, Charny M. Which of two individuals do you treat when only their ages are different and you can't treat both? J Med Ethics 1989; 15: 28-34
14. Murray C. Rethinking DALYs. In: Murray C, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge (MA): WHO, Harvard University Press, 1996
15. Johannesson M, Gerdtham U-G. A note on the estimation of the equity-efficiency trade-off for QALYs. J Health Econ 1996; 15: 359-68
16. Olsen JA. Persons vs years: two ways of eliciting implicit weights. Health Econ 1994; 3: 39-46
17. Llewellyn-Thomas H, Sutherland HJ, Tibshirania R. Describing health states: methodological issues in obtaining values for health states. Med Care 1984; 22: 543-52
18. Gilson L. Government health care charges: is equity being abandoned? London: Evaluation and Planning Centre for Health Care, London School of Hygiene & Tropical Medicine, 1988
19. Olsen JA. Aiming at what? The objectives of the Norwegian health service. In: Alban A, Christiansen T, editors. The nordic health care system. Odense: Odense University Press, 1994
20. Broome J. Trying to value a life. J Public Econ 1978; 9: 91-100
21. George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics 2001; 19: 1-8
22. Ng Y-K. Welfare economics: introduction and development of basic concepts. Rev. ed. Basingstoke: Macmillan Press, 1983
23. Nord E. The trade-off between severity and treatment effect in cost-value analysis of health care. Health Policy 1993; 24: 227-38
24. Nord E, Pinto JL, Richardson J, et al. Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ 1999; 8: 25-39
25. Stolk EA, van Donselaar G, Brouwer WBF, et al. Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics 2004; 22 (17): 1097-107
26. Barendregt JJ, Bonneux L, Van der Maas PJ. DALYs: the age-weights on balance. Bull World Health Organ 1996; 74 (4): 439-43
27. Østerdal LP. A note on cost-value analysis. Health Econ 2003; 12 (3): 247-50
28. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ 1997; 16: 685-702
29. Dolan P, Cookson R, Ferguson B. Effect of discussion and deliberation on the public's views of priority setting in health care: focus group study. BMJ 1999; 318: 916-9
30. Department of Health and Ageing. Other relevant factors and the "rule of rescue": ratified at the March 2003 meeting of the Pharmaceutical Benefits Advisory Committee meeting; 2004; Commonwealth of Australia, Canberra [online]. Available from URL: http://www.dhac.gov.au/ internet/wcms/publishing.nsf/Content/health-pbs-general-pubs-pharmpac-relevant. htm-copy2 [Accessed 2005 Oct 26]
31. Hadorn D. Setting health care priorities in Oregon: cost-effectiveness meets the rule of rescue. JAMA 1991; 265 (17): 2218-25
32. Department of Health and Ageing. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee including Major submissions involving economic analyses: September 2002. Commonwealth of Australia, Canberra, 2002 [online]. Available from URL: http://www.dhac.gov.au/internet/wcms/publishing.nsf/Content/health-pbs-general- pubs-guidelines-content.htm [Accessed 2005 Oct 26]
33. Wonder M, de Abreu Lourenco R. Factors considered in pharmaceutical reimbursement in Australia: a role for the rule of rescue? Paper presented at ISPOR First Asia-Pacific Conference; 2003 Sep 1-3; Kobe [online]. Available from URL: https://www.ispor.org/conferences/kobe0903/fin-PROGRAM.pdf [Accessed 2005 Oct 26]
34. Olsen JA, Smith RD. Theory versus practice: a review of willingness to pay in health and health care. Health Econ 2001; 10: 39-52
35. Donaldson C, Shackley P. Willingness to pay for health care. In: Scott A, Maynard A, Elliott R, editors. Advances in health economics. London: John Wiley, 2003
36. Shackley P, Donaldson C. Using willingness to pay to elicit community preferences for health care: is an incremental approach the way forward? J Health Econ 2002; 21: 971-91
37. Ryan M. Using conjoint analysis in health care to elicit patients' preferences. London: Office of Health Economics, 1996
38. Smith RD, Olsen JA, Harris A. Resource allocation decisions and the use of willingness-to-pay as a valuation technique within economic evaluation: recommendations from a review of the literature. Melbourne (VIC): Centre for Health Program Evaluation, Monash University, 1999
39. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines: similarities, differences and some implications. Value Health 2001; 4 (3): 225-50
40. Cookson R. Willingness to pay methods in health care: a septical view. Health Econ 2003; 12: 891-4